arrow
Back
D

David S.P. Tan

asia-pacific gynecologic oncology trials group

50H-index
399Paper Count
1.0WCitation Count
Published Papers 125
Publication Date
Mes/Stem-A ovarian cancer subtypes predict sensitivity to ATR inhibition
err2026-06-11
err0
errOAAI
errVignesh Sundararajan; Fang Ziyu; Gamal Ahmed Elfar; Tuan Zea Tan; Kuee Theng Kuay; Agnes Tan; Clemence Lai; Antje Margret Wengner; Huynh The Hung; Maili Qi; Wen Yee Chay; Chit Fang Cheok; David Shao Peng Tan
errShare
errSave
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer
err2026-04-25
err0
errOAAI
errJoan Choo; Joseph J. Zhao; Mai Chan Lau; Alessandra Raimondi; Willa Wen-You Yim; Sruthi Ranganathan; Kexin Zhu; Crystal Tze Ying Tan; Hui Xian Chin; Chong Boon Teo; Khi Yung Fong; Ryan Yong Kiat Tay; Jia-Ying Joey Lee; Lit-Hsin Loo; Paolo Manca; Federica Morano; Michele Prisciandaro; Giovanni Randon; Camilla Damonte; Elisa Micarelli; Guido Leoni; Elisa Scarselli; Sara Lonardi; Chiara Cremolini; Federica Marmorino; Jeffrey Chun Tatt Lim; Zhen Wei Neo; Felicia Wee; Li Yen Chong; Craig Ryan Joseph; Akhila Balachander; Diana GS Lim; You Yi Hwang; Laurent Renia; Subhra Kumar Biswas; David Tan; Joe P. S. Yeong; Raghav Sundar; Filippo Pietrantonio
errShare
errSave
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building aPan-Asian and Oceania women's cancer research organization (vol 34, e33, 2023)
err2025-11-01
err0
errOAAI
errTan, David; Fujiwara, Noriko; Fujiwara, Keiichi; Beale, Philip; Kim, Jae-Weon; Ng, Joseph; Kim, Se Ik; Evans, Alison; Kim, Byoung-Gie
errShare
errSave
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
err2025-10-20
err0
errOAAI
errM.M. Zheng; Y. Xia; K. Pan; F. Sun; A. Tan; X.R. Dong; H.Y. Tu; L.B. Tang; Y.S. Li; K. Yin; M. Borgeaud; S. Singhal; E. Zhu; J. Zhang; M. Nilsson; J. Wu; D. Gibbons; H. Wakelee; J.W. Neal; J. Lee; A.A. Vaporciyan; W. Ringsurongkawong; H. Tran; R.Z. Zhang; T. Zhang; Q. Zhou; W.Z. Zhong; W. Li; Y.C. Zhang; J.W. Riess; A. Addeo; J.V. Heymach; N. Myall; D. Tan; Y.L. Wu; X. Le
errShare
errSave
Evaluating a Patient-Centered Education Initiative in Preventing Pre-analytical Errors and Improving Patient Satisfaction in Clinical Diagnostic Laboratories
err2025-10-01
err0
errOAAI
errAsare-Werehene, Meshach; Bohn, Mary Kathryn; Aila, Sri Kirthana; Phillips, Anne Marie; Thomas, Rohan; Nazimek, Katherine; Qiang, Judy Kexin; Rozmanc, Mary; Tan, David; Harth, Tamara; Legere, Laurie; Yip, Paul; Fu, Lei
errShare
errSave
A randomized, phase III study of sacituzumab govitecan versus treatment of physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)
err2025-09-07
err0
PREAI
errRamez N. Eskander; Bradley Corr; David Cibula; David S.P. Tan; Noelle Cloven; Eva Guerra; Kosei Hasegawa; Tashanna Myers; Benoit You; Vicky Makker; Flora Zagouri; Lilian T. Gien; Michele Bartoletti; Adrianne Mallen; Linn Woelber; Simonetta Mocci; Kimberly Komatsubara; Long Ma; Nicoletta Colombo
errShare
errSave
Plasma bictegravir/emtricitabine/tenofovir alafenamide concentrations in transgender women with HIV on oestrogen-based gender-affirming hormone therapy in comparison to cisgender women living with HIV
err2025-09-03
err0
errOAAI
errS. Sunagawa; M. Loutfy; A. Tseng; A. Lacombe-Duncan; Y. Persad; R. Fung; I. Armstrong; L. Chan; Q. Nguyen; S. Hranilovic; D. Tan; R. Halpenny; N. Jeyarajah; J. McCully; K. Scarsi
errShare
errSave
A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients
err2025-07-22
err0
errOAAI
errKenneth Sooi; Tuan Zea Tan; Jae-Weon Kim; Jung Yun Lee; Byoung-Gie Kim; David Micklem; Akil Jackson; David J. Pinato; Charlie Gourley; Rebecca Kristeleit; Sarah P. Blagden; Line Bjorge; David Shao Peng Tan
errShare
errSave
Clearer Horizons: The latest advances in clear cell ovarian cancer treatment
err2025-06-13
err0
PREAI
errFelix Blanc-Durand; Natalie Ngoi; Diana Lim; Isabelle Ray-Coquard; David SP Tan
errShare
errSave
NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies
err2025-06-09
err0
errOAAI
errJoan R. Choo; Santhiay Nathan Jeraj; Raghav Sundar; Wei Peng Yong; Matilda Lee; Yiqing Huang; Yugarajah Asokumaran; Gloria H. J. Chan; Natalie Y. L. Ngoi; Andrea L. A. Wong; Ross A. Soo; Cheng Ean Chee; Joline S. J. Lim; Boon Cher Goh; Soo Chin Lee; David S. P. Tan
errShare
errSave
First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab (anti-PD-1), in patients with advanced malignancies
err2025-06-01
err0
PREAI
errF. Janku; D.S.P. Tan; J. Martin-Liberal; S. Takahashi; R. Geva; A. Gucalp; A. Razak; R. Kan; R. Reiners; J. Mataraza; S. Szpakowski; K. Subramanian; X. Chen; C. Lai; P.L. Bedard
errShare
errSave
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients
err2025-05-05
err0
PREAI
errCherifi, Francois; Ray-Coquard, Isabelle; Rubio, Maria Jesus; Paoletti, Xavier; Lorusso, Domenica; Choi, Chel Hun; Hasegawa, Kosei; Tan, David Shao Peng; Hudson, Emma; Davis, Alison; Tognon, Germana; Lheureux, Stephanie; Vardar Key, Mehmet Ali; Kurtz, Jean Emmanuel; Alexandre, Jerome; Joly, Florence
errShare
errSave
A multi-task domain-adapted model to predict chemotherapy response from mutations in recurrently altered cancer genes
err2025-02-01
err0
errOAAI
errJayagopal, Aishwarya; Walsh, Robert J.; Hariprasannan, Krishna Kumar; Mariappan, Ragunathan; Mahapatra, Debabrata; Jaynes, Patrick William; Lim, Diana; Tan, David Shao Peng; Tan, Tuan Zea; Pitt, Jason J.; Jeyasekharan, Anand D.; Rajan, Vaibhav
errShare
errSave
Third International Arabic Women's Cancer Days and sixth Gynecologic Cancer InterGroup - Cervix Cancer Research Network symposium 2024 in Morocco
err2025-01-01
err0
PREAI
errDerin, Xezal; Bilir, Esra; Nasser, Sara; Elghanmi, Adil; Brand, Alison; Nout, Remi; Chavez-Blanco, Adriana; Bennett, Katherine; Tan, David; Sehouli, Jalid
errShare
errSave
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)
err2025-01-01
err0
PREAI
errLee, Jung-Yun; Tan, David; Ray-Coquard, Isabelle; Lee, Jung Bok; Kim, Byoung Gie; Van Nieuwenhuysen, Els; Huang, Ruby Yun-Ju; Tse, Ka Yu; Gonzalez-Martin, Antonio; Scott, Clare; Hasegawa, Kosei; Wilkinson, Katie; Yang, Eun Yeong; Lheureux, Stephanie; Kristeleit, Rebecca
errShare
errSave
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in platinum sensitive recurrent ovarian cancer and long-term outcomes
err2024-09-01
err0
PREAI
errHaggstrom, L. R.; Lee, Y. C.; Scott, C. L.; Ledermann, J. A.; Gourley, C.; McNeish, I.; Amant, F.; Ray-Coquard, I. L.; Leary, A.; Oza, A. M.; Tinker, A.; Gonzalez-Martin, A.; Cecere, S. C.; Colombo, N.; Yoshida, H.; Marth, C.; Gomez Garcia, E. M.; Tan, D. S.; Moore, K. N.; Friedlander, M. L.
errShare
errSave
Pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/APGOT-OV3)
err2024-09-01
err0
PREAI
errNgoi, N.; Lee, J-Y.; Lim, D.; Thian, Y. L.; Lim, Y. W.; Chan, J. J.; Chay, W. Y.; Zhang, Z.; Gopinathan, A.; Lim, S. E.; Low, J.; Ng, J.; Tong, P.; Lee, Y. J.; Park, J.; Kim, J-W.; Zhu, J.; Tai, B. C.; Kim, B-G.; Tan, D. S.
errShare
errSave
Unlocking the circulating immune landscape of advanced clear-cell ovarian cancer: Insights from the MOCCA trial
err2024-09-01
err0
PREAI
errBlanc-Durand, F.; Ngoi, N.; Kaliaperumal, N.; Au, V. Bijin; Talib, N. B. S. N.; Sng, R.; Chong, J.; Choi, C. H.; Zhu, J.; Lim, D.; Tan, T. Z.; Heong, V. Y. M.; Chay, W. Y.; Kim, H. S.; Lim, Y. W.; Kim, J-W.; Tai, B. C.; Kim, K.; Connolly, J.; Tan, D. S.
errShare
errSave
A phase II trial of a neural network-based treatment decision support tool in patients (pts) with refractory solid organ malignancies
err2024-09-01
err0
PREAI
errWalsh, R. J.; Jayagopal, A.; Tan, T. Z.; Pitt, J.; Sundar, R.; Lee, S. C.; Goh, B-C.; Rajan, V.; Tan, D. S.; Jeyasekharan, A. D.
errShare
errSave